Stem Cells for Drug Developers

Venue: Boston

Location: Boston, Massachusetts, United States

Event Date/Time: Mar 27, 2012 End Date/Time: Mar 29, 2012
Report as Spam


Overcoming the Practical and Scientific Challenges of iPS and ESC Cell Models
The 2nd Stem Cells for Drug Developers Summit will bring together representatives from large and innovative drug developers and leading academic researchers to address the SCIENTIFIC challenges relating to the use of stem cells in drug development.
What’s covered on the agenda?
The 2nd Stem Cells for Drug Developers meeting aims to build on the success of our first meeting, bringing together scientific leaders from pharma, academia and suppliers to address the current scientific and practical barriers and discuss new opportunities to revolutionize your drug development process using stem cells.
• Understand new processes in stem cell differentiation and proliferation
• Evaluate the use of stem cell-derived models for toxicology and safety assessment
• Recapitulate disease phenotypes in derived cells
• Examine whether iPS cells can be a valid substitution for ESCs
• Discuss approaches towards developing fully mature cell populations
• Overcome challenges in stem cell production- making sufficient numbers for drug development
• Forecast the applicability of iPS cells in individualized safety & efficacy screening
• Discover how the unique properties of stem cells can be used in vaccine production

For more information on what will be covered in the meeting and to see the full speaker line up, please visit:


13 - 15 Carteret St
United States